Identification of LCN1 as a Potential Biomarker for Breast Cancer by Bioinformatic Analysis
Author:
Affiliation:
1. Department of Breast Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, P.R. China.
2. Department of R&D Technology Center, Beijing Zhicheng Biomedical Technology Co. Ltd., Beijing, P.R. China.
Publisher
Mary Ann Liebert Inc
Subject
Cell Biology,Genetics,Molecular Biology,General Medicine
Link
https://www.liebertpub.com/doi/pdf/10.1089/dna.2019.4843
Reference32 articles.
1. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
2. CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension
3. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
4. Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker
5. Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma;American Journal of Surgical Pathology;2024-04-29
2. Bioinformatic Analysis of BRCA for Breast, Ovary and Lung Cancer;2023 International Conference on Computational Intelligence and Sustainable Engineering Solutions (CISES);2023-04-28
3. Reduced Expression of SFRP1 is Associated with Poor Prognosis and Promotes Cell Proliferation in Breast Cancer: An Integrated Bioinformatics Approach;Indian Journal of Gynecologic Oncology;2022-10-28
4. Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma;Frontiers in Oncology;2022-10-20
5. Targeted proteomics using parallel reaction monitoring confirms salivary proteins indicative of metastatic triple-negative breast cancer;Journal of Proteomics;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3